Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570)
Unit Dose Services
MECLIZINE HYDROCHLORIDE
MECLIZINE HYDROCHLORIDE 25 mg
ORAL
PRESCRIPTION DRUG
INDICATIONS Based on a review of this drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications as follows: Effective: Management of nausea and vomiting, and dizziness associated with motion sickness. Possibly Effective: Management of vertigo associated with diseases affecting the vestibular system. Final classification of the less than effective indications required further investigation. Meclizine hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it.
Product: 50436-3988 NDC: 50436-3988-1 30 TABLET in a BOTTLE NDC: 50436-3988-3 90 TABLET in a BOTTLE
Abbreviated New Drug Application
MECLIZINE HYDROCHLORIDE- MECLIZINE HYDROCHLORIDE TABLET UNIT DOSE SERVICES ---------- RX ONLY DESCRIPTION Meclizine hydrochloride, an oral antiemetic, is a white, slightly yellowish, crystalline powder which has a slight odor and is tasteless. It has the following structural formula: C H CIN •2HCI•H O M.W. 481.89 The chemical name is 1-(_p_-chloro-alpha-phenylbenzyl)-4-(_m_-methyl-benzyl) - piperazine dihydrochloride monohydrate. Meclizine Hydrochloride Tablets are available in 12.5 mg, and *25 mg strengths for oral administration. *Contains FD&C Yellow #5 (see PRECAUTIONS). Each tablet contains the following inactive ingredients: colloidal silicon dioxide, lactose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, starch, and stearic acid. In addition, the 12.5 mg tablet contains FD&C Blue #1; and the 25 mg tablet contains D&C Yellow #10 and FD&C Yellow #5. CLINICAL PHARMACOLOGY Meclizine hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum. _PHARMACOKINETICS_ The available pharmacokinetic information for meclizine following oral administration has been summarized from published literature. _ABSORPTION_ Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form. _DISTRIBUTION_ Drug distribution characteristics for meclizine in humans in unknown. _METABOLISM_ The metabolic fate of meclizine in humans in unknown. In an i_n vitro _metabolic study using human hepatic microsome and recombinant CYP enzyme, CYP2D6 was found to be the dominant enzyme for 25 27 2 2 max metabolism of meclizine. The genetic polymorphism Lugege kogu dokumenti